Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AstraZeneca PLC | Stockholm | Healthcare | Pharmaceuticals | SEK 2.25T | 32.9x | 1.8 | SEK 1,456 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.5% Upside | Upgrade to Pro+ | |
Swedish Orphan Biovitrum | Stockholm | Healthcare | Pharmaceuticals | SEK 96.44B | 24.7x | 0.5 | SEK 280.80 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.3% Upside | Upgrade to Pro+ | |
Getinge B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 58.79B | 35.9x | -1.15 | SEK 205.40 | -5.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.7% Upside | Upgrade to Pro+ | |
Sectra | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 48.42B | 82.2x | 2.08 | SEK 251 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.2% Downside | Upgrade to Pro+ | |
Camurus AB | Stockholm | Healthcare | Pharmaceuticals | SEK 33.10B | 76.4x | -19.93 | SEK 565 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.5% Upside | Upgrade to Pro+ | |
Medicover | Stockholm | Healthcare | Healthcare Providers & Services | SEK 30.70B | 171.5x | -29.33 | SEK 205 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.5% Upside | Upgrade to Pro+ | |
Vimian Group AB | Stockholm | Healthcare | Pharmaceuticals | SEK 23.10B | 100.6x | 1.3 | SEK 41 | -7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.8% Upside | Upgrade to Pro+ | |
Vitrolife | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 22.05B | 43.1x | 0.39 | SEK 162.80 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bonesupport | Stockholm | Healthcare | Pharmaceuticals | SEK 20.82B | 155.4x | -3.19 | SEK 316.40 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.8% Upside | Upgrade to Pro+ | |
Elekta B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 19.31B | 18.6x | -0.72 | SEK 50.20 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.8% Upside | Upgrade to Pro+ | |
AddLife | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 18.08B | 71.7x | 2.22 | SEK 148.40 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.1% Upside | Upgrade to Pro+ | |
BioArctic | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 15.49B | -87.7x | 0.54 | SEK 175.50 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioGaia B | Stockholm | Healthcare | Pharmaceuticals | SEK 10.97B | 31.2x | -7.96 | SEK 108.40 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42% Upside | Upgrade to Pro+ | |
Arjo | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 9.51B | 19.1x | 5.41 | SEK 34.70 | -6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.5% Upside | Upgrade to Pro+ | |
Ambea | Stockholm | Healthcare | Healthcare Providers & Services | SEK 8.99B | 14.9x | 0.36 | SEK 107.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.3% Upside | Upgrade to Pro+ | |
Attendo International publ AB | Stockholm | Healthcare | Healthcare Providers & Services | SEK 8.99B | 20.9x | 0.91 | SEK 59.80 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.9% Upside | Upgrade to Pro+ | |
Xvivo Perfusion AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 8.80B | 50.7x | 0.71 | SEK 278 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Implantica AG | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 8.13B | -42.3x | -21.28 | SEK 28 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
RaySearch Labs B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 7.66B | 37.7x | 0.26 | SEK 223.50 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.7% Upside | Upgrade to Pro+ | |
Biotage AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 7.54B | 26.6x | 4.18 | SEK 94 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Surgical Science Sweden | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 6.17B | 46.8x | -1.12 | SEK 120 | -5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Swedencare | Stockholm | Healthcare | Pharmaceuticals | SEK 5.93B | 60.1x | 0.92 | SEK 37.30 | -6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.9% Upside | Upgrade to Pro+ | |
CellaVision AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 3.95B | 28.1x | 3.57 | SEK 164.40 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.6% Upside | Upgrade to Pro+ | |
Flerie AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3.26B | -12.9x | -0.21 | SEK 42.30 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.6% Upside | Upgrade to Pro+ | |
Medistim ASA | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 2.99B | 30.2x | SEK 170.14 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Humana | Stockholm | Healthcare | Healthcare Providers & Services | SEK 2.24B | 15x | -0.7 | SEK 42.90 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.4% Upside | Upgrade to Pro+ | |
BICO Group | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 2.12B | -23.4x | -0.25 | SEK 29.76 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Stille AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.99B | 34x | 1.61 | SEK 221 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.1% Upside | Upgrade to Pro+ | |
BioInvent International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.84B | -4.3x | 0.15 | SEK 28 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cereno Scientific | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.68B | -17x | 0.23 | SEK 5.98 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SyntheticMR | Spotlight | Healthcare | Healthcare Equipment & Supplies | SEK 1.65B | -10.4x | 0.06 | SEK 4.02 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Devyser Diagnostics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.64B | -34.9x | 2.11 | SEK 96 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vicore Pharma Holding AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.64B | -5.6x | -0.16 | SEK 6.94 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Egetis Therapeutics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.55B | -3.9x | -0.28 | SEK 4.31 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carasent AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.55B | -38.6x | -11.53 | SEK 21.81 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.6% Upside | Upgrade to Pro+ | |
Hansa Biopharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.54B | -1.8x | -0.1 | SEK 22.64 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intellego Technologies AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.40B | 13.7x | 1.15 | SEK 46.25 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Paxman | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.35B | 33.8x | 0.09 | SEK 70.60 | -4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.4% Upside | Upgrade to Pro+ | |
Genovis AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.26B | 37.8x | -0.8 | SEK 18.96 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OssDsign | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.16B | -24.3x | -0.34 | SEK 11.88 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.2% Upside | Upgrade to Pro+ | |
Nanoform Finland Plc | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.10B | -3.7x | 0.69 | SEK 12.76 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XSpray Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.07B | -3.3x | 0.14 | SEK 28.90 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bactiguard Holding AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 998.75M | -33.8x | -0.44 | SEK 28.50 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Enzymatica publ AB | Stockholm | Healthcare | Pharmaceuticals | SEK 970.94M | -14.3x | -2.12 | SEK 4 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -30.7% Downside | Upgrade to Pro+ | |
C-Rad | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 930.12M | 16.5x | 0.29 | SEK 27.70 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SynAct Pharma AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 882.16M | -8.1x | -0.14 | SEK 17.94 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.5% Downside | Upgrade to Pro+ | |
ADDvise Group AB A | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 878.85M | 2.5x | -0.17 | SEK 4.42 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Diamyd Medical | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 878.50M | -5.2x | 0.55 | SEK 8.43 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sedana Medical | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 775.82M | -70.8x | -1 | SEK 7.82 | -5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nykode Therapeutics | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 733.07M | -1.9x | SEK 13.98 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |